SCHEMBL22719247

SCHEMBL22719247

O=C(c1cccnc1-c1ccncn1)N1CCC(Cc2ccc(F)c(F)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 4/20 0.54
▸ CYP2C9 P11712 4/20 0.47
▸ CYP2C19 P33261 4/20 0.47
▸ MAPK14 Q16539 4/20 0.47
▸ CCR3 P51677 1/20 0.45
▸ MGLL Q99685 4/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ HTR2B P41595 3/20 0.41
▸ HTT P42858 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ FAAH O00519 1/20 0.40
▸ MLNR O43193 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29453734 1.00 CYP46A1 (0.54) CYP46A1CYP2C9CYP2C19MAPK14CCR3
SCHEMBL22719343 0.90 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19MAPK14CCR3
SCHEMBL29453806 0.90 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19MAPK14CCR3
SCHEMBL22719301 0.86 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19MAPK14CCR3
SCHEMBL22719425 0.83 CYP46A1 (0.52) CYP46A1CYP2C9CYP2C19MAPK14CCR3
SCHEMBL29453783 0.83 CYP46A1 (0.52) CYP46A1CYP2C9CYP2C19MAPK14CCR3
SCHEMBL14849085 0.83 CYP46A1 (0.76) CYP46A1CYP2C9CYP2C19CYP3A4
SCHEMBL22719424 0.80 CYP46A1 (0.59) CYP46A1CYP2C9CYP2C19CYP3A4
SCHEMBL29453742 0.80 CYP46A1 (0.59) CYP46A1CYP2C9CYP2C19CYP3A4
SCHEMBL22719130 0.77 MLNR (0.57) CYP46A1CYP2C9CYP2C19MAPK14HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback